Mesoblast operational highlights and upcoming milestones

New york, march 30, 2021 (globe newswire) -- mesoblast limited (nasdaq:meso; asx:msb), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an overview of the company's recent operational highlights, as well as upcoming milestones.

MESO Ratings Summary

MESO Quant Ranking